Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EVI5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GIGYF2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CTBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C16orf46 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ERAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TAF13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MTO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAG4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WDR20 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP76 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DPM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CREBBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
REL - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOX2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPID - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPS8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CALR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBE2F - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
YEATS4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on